Mingqi Zheng

ORCID: 0000-0003-1649-7296
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • Atrial Fibrillation Management and Outcomes
  • Phytochemical Studies and Bioactivities
  • Ferroptosis and cancer prognosis
  • Acute Myocardial Infarction Research
  • Cancer-related molecular mechanisms research
  • Cardiac Fibrosis and Remodeling
  • Bioactive natural compounds
  • Traditional Chinese Medicine Analysis

Hebei Medical University
2023

First Affiliated Hospital of Hebei Medical University
2022-2023

Compound Kushen injection (CKI) is a type of traditional Chinese medicine that has previously been studied for the treatment various types cancer. Previous studies have reported CKI regulates cell apoptosis by downregulating PI3K/Akt pathway. The present study aimed to determine whether alleviates heart failure (HF) attenuating cardiomyocyte via inhibition Angiotensin II (Ang II) was used elicit HF, and osmotic minipumps with either Ang (2 µg/kg/day) or phosphate‑buffered saline (PBS; 200...

10.3892/ijmm.2023.5226 article EN cc-by-nc-nd International Journal of Molecular Medicine 2023-01-30

Abstract The current diagnostic biomarkers of acute myocardial infarction (AMI), troponins, lack specificity and exist as false positives in other non-cardiac diseases. Previous studies revealed that cuproptosis, ferroptosis, immune infiltration are all involved the development AMI. We hypothesize combining analysis AMI will help identify more precise biomarkers. results showed a total 19 cuproptosis- ferroptosis-related genes (CFRGs) were differentially expressed between healthy groups....

10.21203/rs.3.rs-2586355/v1 preprint EN cc-by Research Square (Research Square) 2023-02-20
Coming Soon ...